With consumer staples out of favor and a yield surpassing the S&P 500, Coca-Cola's resilient business and decades of dividend growth present a compelling case for long-term investors.
The Norwegian Nobel Committee has concluded that a pre-announcement leak of the 2025 Peace Prize laureate's name was likely the result of digital espionage, raising serious questions about the security of the prestigious award and the motives behind the breach.
Pakistan's military says it has killed 41 armed fighters in two separate raids in restive Balochistan province, alleging—without presenting evidence—that the militants were supported by regional rival India. The operations come amid a surge in violence in the region.
Iranian Foreign Minister Abbas Araghchi, during a visit to Istanbul, stated Tehran is open to dialogue in principle but has no current plans for negotiations with Washington. The announcement comes amid heightened regional tensions and a Turkish offer to facilitate talks.
After a three-year suspension due to insurgent violence, TotalEnergies and Mozambique have agreed to restart one of Africa's largest natural gas developments, raising hopes for economic transformation amid lingering risks.
CNBC's Jim Cramer refrained from declaring a floor for Broadcom's stock amid mixed analyst sentiment and growing competition in the crucial AI semiconductor sector.
Medtronic secures a key European regulatory nod for its latest pulsed field ablation catheter while deepening its collaboration with Mindray, signaling a strategic push into high-growth areas of cardiac care and ambulatory surgery.
As the Bank of Canada holds rates steady, speculative capital is sifting through junior resource stocks. We examine three micro-caps—a driller, an explorer, and an oil hopeful—navigating unique challenges and opportunities in early 2026.
American Express reported a 10.6% year-over-year revenue increase to $17.57 billion for the fourth quarter of 2025, yet missed Wall Street's sales expectations. Earnings per share of $3.53 met analyst consensus estimates.
In its Q4 2025 letter, Greenlight Capital revealed a new position in dental distributor Henry Schein (HSIC), arguing the stock presents an opportunity for operational improvement and shareholder returns, despite recent underperformance.
Charles Schwab announces a strategic reorganization, merging its wealth advisory and banking divisions into a single unit led by long-time executive Neesha Hathi, alongside other key leadership changes.
In a landmark deal, AstraZeneca has licensed a suite of next-generation weight-loss drugs from China's CSPC, aiming to challenge the dominance of Lilly and Novo Nordisk with longer-acting monthly injectables.
The AI-as-a-Service (AIaaS) market is witnessing significant growth, fueled by cloud innovation and corporate demand for scalable AI solutions. While data privacy remains a hurdle, the integration of generative AI and tailored platforms is accelerating adoption across industries.
As Eli Lilly prepares to report its Q4 and full-year 2025 results on February 4th, investors are weighing whether the pharmaceutical giant's premium valuation leaves room for a positive surprise, or if the stock is priced for perfection.
Newly launched oral weight-loss drug Wegovy from Novo Nordisk recorded more than 26,000 U.S. prescriptions in its second full week, signaling robust early demand as competition with Eli Lilly intensifies.
A new industry analysis reveals the apparel and textiles sector is falling dangerously behind on its climate commitments, with progress too slow to meet critical international targets.
Amid market volatility, these three companies offering yields above 4% present a compelling case for income-focused investors, backed by strategic pivots and resilient business models.
Fresh Israeli military actions in central and southern Gaza have resulted in multiple casualties, testing the durability of a months-long, U.S.-brokered truce and hindering critical aid flows.
Lam Research capitalizes on soaring demand for AI chipmaking equipment, reporting record quarterly and annual revenue. While the company is aggressively expanding capacity to address supply chain bottlenecks, some analysts question if its valuation already reflects the AI-driven growth.
While major indices tread water ahead of key earnings, a segment of the market continues to buzz with activity. We examine three micro-cap companies—Hongli Group, Royalty Management, and CreateAI—whose financial profiles and strategic moves are capturing attention from investors willing to navigate the high-risk, high-reward penny stock arena.
